Ultra Whitening Cream | Clobetasol Cream BP 0.05% W/W – 50 GM

Icona London Ultra Whitening Cream 50 GM | Clobetasol Cream BP 0.05% W/W | Super-Potent Topical Corticosteroid | 6 Colour-Coded Packs | Use Under Medical Direction

Icona London Ultra Whitening Cream – Clobetasol Cream BP 0.05% W/W – 50 GM is a topical dermatological cream presented in six colour-coded packaging designs. The front packaging identifies the formulation as Clobetasol Cream BP 0.05% W/W and also displays “Ultra Whitening,” “Exclusive Formula,” “Serum in Cream” and “Fast Action Spot Remover” positioning.

Because clobetasol 0.05% is a very potent topical corticosteroid, this product should be treated primarily as a dermatological medicine rather than an ordinary cosmetic face or whitening cream. Authoritative clobetasol labeling describes 0.05% cream as a super-high-potency corticosteroid used for inflammatory and itchy manifestations of corticosteroid-responsive skin disorders.

Clobetasol works by reducing inflammatory responses in the skin and is used under medical direction for appropriate skin conditions. MedlinePlus notes that topical clobetasol is used for symptoms including inflammation, redness and itching associated with certain skin disorders and should be used exactly as directed.

The 50 GM tube provides a clearly defined topical cream format. The product is shown in six visually differentiated packs: Blue, Coral/Orange, Green, Orange/Gold, Red and Yellow. Whether these colours represent different formulations, fragrances or simply packaging variations cannot be confirmed from the supplied images, so individual variant specifications should be verified before ecommerce publication.

Safety and appropriate use are particularly important with clobetasol. FDA-regulated labeling for clobetasol propionate cream 0.05% warns that prolonged or excessive use can increase systemic corticosteroid exposure and potentially suppress the hypothalamic-pituitary-adrenal axis. It also advises against use on the face, groin or underarms for the referenced formulation.

Long-term clobetasol use can also contribute to adverse skin effects such as thinning or stretch marks, and systemic effects can occur if enough medicine is absorbed. Therefore, cosmetic use for general skin lightening, fairness enhancement or unsupervised spot removal should not be recommended solely on the basis of the front-of-pack marketing language.

For B2C customers, this product should be supplied and used only according to applicable local medicine regulations and professional medical advice. Consumers should read the complete leaflet, warnings and directions before use and should not apply the product more frequently, over larger areas or for longer periods than instructed.

For B2B buyers, Icona London Clobetasol Cream BP 0.05% W/W may be relevant to regulated pharmacies, pharmaceutical distributors, healthcare wholesalers and authorized medical-product channels, subject to country-specific registration, prescription and sale requirements.

The exact inactive ingredients, manufacturer authorization, prescription classification, approved indications and six variant differences remain To Be Confirmed from official product documentation.